Our ongoing commitment to improving outcomes and quality of life for people affected by cancer depends on a range of factors. One of the most vital is our opportunity to access funding by way of research grants to support our efforts.
According to the National Health and Medical Research Council (NHMRC), one researcher has the potential to improve millions of lives. For more than three decades, TROG Cancer Research has committed its efforts to this goal.
TROG Cancer Research has a dedicated team supporting our Members in their quests for securing grants to facilitate cancer research funding.
Read on to discover the current grant funding opportunities available.
| FUNDING BODY | GRANT | DETAILS | OPENING DATE | MIN DATA DUE | CLOSING DATE |
|---|---|---|---|---|---|
| NHMRC | Development Grants (NHMRC) | The Development Grant scheme provides financial support to individual researchers and/or research teams to undertake health and medical research within Australia at the proof-of-concept stage that specifically drives towards a commercial outcome within a foreseeable timeframe. | 20.04.2022 | 18.05.2022 | 15.06.2022 |
| NHMRC | Clinical Trials and Cohort Studies Grants (NHMRC)* | Clinical Trials and Cohort Studies Grants support high-quality clinical trials and cohort studies that address important gaps in knowledge, leading to relevant and implementable findings for the benefit of human health. | 29.06.2022 | 27.07.2022 | 24.08.2022 |
| Tour de Cure | Annual grant | They fund cancer research projects from across Australian are supported that improve cancer outcomes and help find a cure for cancer. All types of cancer research projects may be funded, including those that may not fit into traditional funding schemes, as well as acquisition of equipment or resources to help identify new ways to detect and treat cancer. We find and fund research that, among other things prevents cancer and the related health consequences; develops new treatments or medicines; improves cancer detection and diagnosis; improves quality of life; improves understanding of different cancers; supports clinical trials. | Aug-22 | - | Oct-22 |
| Cancer Australia | Priority-driven Collaborative Cancer Research Scheme | The Priority-driven Collaborative Cancer Research Scheme is an innovative annual national research project grants funding scheme which brings together government and other funders to collaboratively fund cancer research in Australia. | 9.04.2022 | - | 31.08.2022 |
| NHMRC | International Clinical Trial Collaborations (MRFF) round 1 | Funds Australian led international collaborative investigator-initiated clinical trials to improve health practices and outcomes for patients. Also looks to increase opportunities for patients to access novel treatments and therapies growth in the capacity of Australias clinical trials workforce | 30.03.2022 | 20.07.2022 | 3.08.2022 |
| NHMRC | International Clinical Trial Collaborations (MRFF) round 2 | Funds Australian led international collaborative investigator-initiated clinical trials to improve health practices and outcomes for patients. Also looks to increase opportunities for patients to access novel treatments and therapies growth in the capacity of Australias clinical trials workforce | 30.03.2022 | 8.02.2023 | 22.02.2023 |
| MRFF | Partnership Projects 2022 PRC2 | This funding scheme provides funding and support to create new opportunities for researchers and policy makers to work together to define research questions, undertake research, interpret the findings and implement the findings into policy and practice. | 24.03.2022 | 27.07.2022 | 11.08.2022 |
There are currently no travel grants available.
There are currently no education grants available.
For over 30 years, TROG Cancer Research has been dedicated to improving the way radiation medicine is delivered to cancer patients with ongoing scientific research, clinical trials, and cutting-edge technology.
